HDAC1 and glioblastoma: Although several CRISPR/Cas9 screens conducted on hGSCs did not identify HDAC1 as an essential fitness gene governing hGSC growth and survival (63, 64), recent studies corroborate our findings that HDAC1 is an attractive therapeutic target for GBM (23, 24).